Adtalem Global Education (NYSE:CVSA) Downgraded by Zacks Research to “Hold”

Zacks Research cut shares of Adtalem Global Education (NYSE:CVSA) from a strong-buy rating to a hold rating in a report issued on Wednesday,Zacks.com reports.

A number of other research firms have also recently weighed in on CVSA. Barrington Research reissued an “outperform” rating and set a $170.00 price objective on shares of Adtalem Global Education in a report on Monday, March 2nd. Weiss Ratings assumed coverage on shares of Adtalem Global Education in a report on Wednesday, February 25th. They issued a “hold (c+)” rating for the company. Finally, Truist Financial began coverage on shares of Adtalem Global Education in a research report on Tuesday. They issued a “buy” rating and a $130.00 target price on the stock. Two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $150.00.

Adtalem Global Education Stock Up 0.4%

NYSE:CVSA opened at $116.39 on Wednesday. Adtalem Global Education has a 1 year low of $86.97 and a 1 year high of $156.26. The stock has a market cap of $4.02 billion, a PE ratio of 17.09, a price-to-earnings-growth ratio of 0.98 and a beta of 0.72. The company has a quick ratio of 0.68, a current ratio of 0.68 and a debt-to-equity ratio of 0.37.

Adtalem Global Education (NYSE:CVSA) last issued its earnings results on Wednesday, January 28th. The company reported $2.43 earnings per share for the quarter. The business had revenue of $503.39 million for the quarter. Adtalem Global Education had a return on equity of 20.24% and a net margin of 13.41%.

Insider Buying and Selling at Adtalem Global Education

In other news, Director Michael W. Malafronte acquired 8,890 shares of the firm’s stock in a transaction dated Wednesday, March 11th. The stock was acquired at an average cost of $100.94 per share, with a total value of $897,356.60. Following the completion of the acquisition, the director owned 25,395 shares of the company’s stock, valued at $2,563,371.30. The trade was a 53.86% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders purchased 37,236 shares of company stock valued at $3,752,866 over the last three months. 2.50% of the stock is currently owned by corporate insiders.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.